Comparative Risks of Mortality and Fractures in Patients With Osteoarthritis Initiating Tramadol Versus Other Opioids
Arthritis & Rheumatology · 05.11.2026
DOI: 10.1002/art.70383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 05.11.2026. Verfasst von Sushama Kattinakere Sreedhara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass…. Die Arbeit nennt 32 Literaturangaben. Gefördert von: AHRQ HHS, Agency for Healthcare Research and Quality.
Abstract (Originalsprache)
Objective
Tramadol is commonly used to manage pain in patients with osteoarthritis, but its comparative safety in this population remains largely unknown. The study aimed to evaluate the risks of all‐cause mortality and fracture among patients with osteoarthritis initiating tramadol versus other prescribed opioids.
Methods
We conducted a retrospective cohort study using Optum Clinformatics Data Mart (2005–2021). Adults aged ≥50 years with osteoarthritis initiating tramadol, codeine, hydrocodone, or oxycodone were included. Outcomes were all‐cause mortality and fractures. Propensity score weighting balanced baseline characteristics, and weighted Cox proportional hazards models estimated adjusted hazard ratios (HRs) with 95% confidence intervals (CIs).
Results
Among 1,057,635 patients (mean age 69.1 years; 62.5% female), 294,760 initiated tramadol, 97,048 codeine, 474,733 hydrocodone, and 191,094 oxycodone. During follow‐up, 9,988 deaths and 10,455 fractures occurred. Tramadol showed similar mortality risk to codeine (HR 0.93, 95% CI 0.73–1.19) but lower risk compared with hydrocodone (HR 0.81, 95% CI 0.70–0.93) and oxycodone (HR 0.40, 95% CI 0.34–0.47). Fracture risk was comparable to codeine (HR 1.10, 95% CI 0.96–1.25) and lower than hydrocodone (HR 0.91, 95% CI 0.83–0.98) and oxycodone (HR 0.83, 95% CI 0.75–0.93).
Conclusion
In adults aged 50 years or older with osteoarthritis initiating an opioid, tramadol initiation was associated with lower risks of death and fractures compared with hydrocodone and oxycodone, and similar risks compared with codeine. These findings suggest that tramadol may be a comparatively favorable option when opioid therapy is necessary, although its longer‐term comparative safety remains uncertain.
Autor:innen und Institutionen
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
- Department of Orthopedic Surgery and Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
ORCID-Profile: Sushama Kattinakere Sreedhara, Katsiaryna Bykov
Förderung
- AHRQ HHS
- Agency for Healthcare Research and Quality
Zitieren
APA
Kattinakere Sreedhara, S., Bea, S., Huybrechts, K. F., Khan, N. F., Katz, J. N., Belitkar, S., Tong, A. Y., & Bykov, K. (2026). Comparative Risks of Mortality and Fractures in Patients With Osteoarthritis Initiating Tramadol Versus Other Opioids. Arthritis & Rheumatology. https://doi.org/10.1002/art.70383
Vancouver
Kattinakere Sreedhara S, Bea S, Huybrechts KF, Khan NF, Katz JN, Belitkar S, et al. Comparative Risks of Mortality and Fractures in Patients With Osteoarthritis Initiating Tramadol Versus Other Opioids. Arthritis & Rheumatology. 2026. doi:10.1002/art.70383
BibTeX
@article{KattinakereSreedhara2026,
author = {Kattinakere Sreedhara, Sushama and Bea, Sungho and Huybrechts, Krista F and Khan, Nazleen F and Katz, Jeffrey N and Belitkar, Shruti and Tong, Angela Y and Bykov, Katsiaryna},
title = {Comparative Risks of Mortality and Fractures in Patients With Osteoarthritis Initiating Tramadol Versus Other Opioids},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70383}
}
EUVIMED